肥胖的患病率,与健康风险增加相关的疾病,在过去的几十年里大幅上升。虽然肥胖是由能量失衡发展而来的,它的病因涉及许多其他因素。这些因素之一是内分泌干扰物,或“增生剂”,当提到肥胖时。双酚A(BPA),一种已知的用于塑料材料的内分泌干扰物,最近被描述为环境肥胖。尽管不含BPA的产品现在比过去越来越普遍,人们仍然担心替代它的化合物的生性,即双酚S(BPS),双酚F(BPF),和双酚AF(BPAF)。这篇综述的目的是探讨BPA替代品与肥胖之间的关系。通过PubMed和GoogleScholar确定了有关BPA替代品与肥胖之间关系的文献,利用搜索词“双酚A替代品”,“双酚类似物”,\"BPS\",\"BPF\",\"BPAF\",“肥胖”,\"obesogens\",“脂肪生成”,“PPARγ”,和“脂肪细胞分化”。评估了各种基于人群的研究,以更好地了解流行病学,这揭示了证据表明BPA替代品可能在病理生理水平上起到致肥剂的作用。对其他研究进行了评估,以探索这些化合物作为增生剂的潜在机制。对于BPS,这些机制包括过氧化物酶体增殖物激活受体γ(PPARγ)激活,增强高脂肪饮食引起的体重增加,和刺激脂肪细胞肥大和脂肪储库组成。对于BPF和BPAF,证据不足.鉴于目前对这些化合物的理解,对风险敞口有足够的担忧。因此,需要对BPA替代品与肥胖的关系进行进一步研究,以告知可实施的潜在公共卫生措施,以最大限度地减少暴露.
The prevalence of obesity, a condition associated with increased health risks, has risen significantly over the past several decades. Although obesity develops from energy imbalance, its etiology involves a multitude of other factors. One of these factors are endocrine disruptors, or \"obesogens\", when in reference to obesity. Bisphenol A (BPA), a known endocrine disruptor used in plastic materials, has recently been described as an environmental obesogen. Although BPA-free products are becoming more common now than in the past, concerns still remain about the obesogenic properties of the compounds that replace it, namely Bisphenol S (BPS), Bisphenol F (BPF), and Bisphenol AF (BPAF). The purpose of this
review is to investigate the relationship between BPA substitutes and obesity. Literature on the relationship between BPA substitutes and obesity was identified through PubMed and Google Scholar, utilizing the search terms \"BPA substitutes\", \"bisphenol analogues\", \"BPS\", \"BPF\", \"BPAF\", \"obesity\", \"obesogens\", \"adipogenesis\", \"
PPARγ\", and \"adipocyte differentiation\". Various population-based studies were assessed to gain a better understanding of the epidemiology, which revealed evidence that BPA substitutes may act as obesogens at the pathophysiological level. Additional studies were assessed to explore the potential mechanisms by which these compounds act as obesogens. For BPS, these mechanisms include Peroxisome proliferator-activated receptor gamma (
PPARγ) activation, potentiation of high-fat diet induced weight-gain, and stimulation of adipocyte hypertrophy and adipose depot composition. For BPF and BPAF, the evidence is more inconclusive. Given the current understanding of these compounds, there is sufficient concern about exposures. Thus, further research needs to be conducted on the relationship of BPA substitutes to obesity to inform on the potential public health measures that can be implemented to minimize exposures.